NHU(SZ:002001)2015-02-26 16:00Financial Performance - Total revenue for 2014 was CNY 4,163.84 million, a decrease of 1.74% compared to CNY 4,237.63 million in 2013[4] - Operating profit for 2014 was CNY 1,003.59 million, down 3.38% from CNY 1,038.69 million in 2013[4] - Net profit attributable to shareholders for 2014 was CNY 808.26 million, representing an 8.37% decline from CNY 882.12 million in 2013[4] - Basic earnings per share for 2014 decreased to CNY 0.74, down 8.64% from CNY 0.81 in 2013[4] - The weighted average return on equity decreased by 2.08 percentage points in 2014[4] - There were no discrepancies between the reported operating performance and the previous earnings forecast[7] Assets and Equity - Total assets increased by 6.65% to CNY 9,124.76 million in 2014, compared to CNY 8,555.87 million in 2013[4] - Shareholder equity attributable to the company increased by 6.77% to CNY 7,015.39 million in 2014, up from CNY 6,570.56 million in 2013[4] - The number of shares increased by 50% to 1,088.91 million shares in 2014 from 725.95 million shares in 2013[4] Product Performance - The company’s main product, Vitamin E, saw a decrease in sales price, while sales volume for Vitamin E and Vitamin A increased[6]